BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15918142)

  • 1. Early hepatocellular carcinoma and dysplastic nodules.
    Kojiro M; Roskams T
    Semin Liver Dis; 2005; 25(2):133-42. PubMed ID: 15918142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.
    Park YN; Kojiro M; Di Tommaso L; Dhillon AP; Kondo F; Nakano M; Sakamoto M; Theise ND; Roncalli M
    Cancer; 2007 Mar; 109(5):915-23. PubMed ID: 17279586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view.
    Kojiro M
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S3-8. PubMed ID: 14762831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of DNA methyltransferases in multistep hepatocarcinogenesis.
    Choi MS; Shim YH; Hwa JY; Lee SK; Ro JY; Kim JS; Yu E
    Hum Pathol; 2003 Jan; 34(1):11-7. PubMed ID: 12605361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological diagnosis at early stage: reaching international consensus.
    Kojiro M
    Oncology; 2010 Jul; 78 Suppl 1():31-5. PubMed ID: 20616581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
    Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
    Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
    Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
    Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathomorphological study on small nodular lesions in hepatitis C virus-related cirrhosis.
    Miyaaki H; Fujimoto M; Kurogi M; Nakashima O; Eguchi K; Kojiro M
    Oncol Rep; 2005 Dec; 14(6):1469-74. PubMed ID: 16273240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of liver cancers.
    Kojiro M
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):39-62. PubMed ID: 15757804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic precancerous lesions and small hepatocellular carcinoma.
    Hytiroglou P; Park YN; Krinsky G; Theise ND
    Gastroenterol Clin North Am; 2007 Dec; 36(4):867-87, vii. PubMed ID: 17996795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of early hepatocellular carcinoma: progression from early to advanced.
    Kojiro M
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1203-5. PubMed ID: 9730375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers.
    Libbrecht L; Cassiman D; Verslype C; Maleux G; Van Hees D; Pirenne J; Nevens F; Roskams T
    Am J Gastroenterol; 2006 Oct; 101(10):2341-6. PubMed ID: 17032200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion-weighted MRI in evaluating the intranodular hemodynamic characteristics of dysplastic nodules and hepatocellular carcinomas in an experimental rat model.
    Xu H; Xie JX; Li X; Yang ZH; Zheng ZZ; Wang B; Wang Z
    J Magn Reson Imaging; 2008 Jan; 27(1):102-9. PubMed ID: 18022847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma antigen in human liver carcinogenesis.
    Guido M; Roskams T; Pontisso P; Fassan M; Thung SN; Giacomelli L; Sergio A; Farinati F; Cillo U; Rugge M
    J Clin Pathol; 2008 Apr; 61(4):445-7. PubMed ID: 17893121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathomorphologic characteristics and differential diagnosis of small hepatocellular carcinoma].
    Nakashima O; Kojiro M
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):827-34. PubMed ID: 8678529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular immunohistochemical markers: contributions to hepatocellular nodule diagnosis in explanted livers.
    Nascimento C; Caroli-Bottino A; Paschoal J; Pannain VL
    Transplant Proc; 2009 Dec; 41(10):4211-3. PubMed ID: 20005371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadoxetate Disodium-Enhanced MRI to Differentiate Dysplastic Nodules and Grade of Hepatocellular Carcinoma: Correlation With Histopathology.
    Channual S; Tan N; Siripongsakun S; Lassman C; Lu DS; Raman SS
    AJR Am J Roentgenol; 2015 Sep; 205(3):546-53. PubMed ID: 26295640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.